MTOR and Familial prostate cancer: Dual PI3K/mTOR inhibition with BEZ235 in patient-derived OSCC cells or prostate cancer cell lines.Treatment of OSCC cell lines with RAD001 inhibitor decreases the phosphorylation and activation of mTOR and increases the RR.